Valuation: PharmaEssentia Corporation

Market Cap 48TCr 1.5TCr 1.31TCr 1.21TCr 1.12TCr 2.11TCr 1,44600Cr 2.14TCr 15TCr 5.69TCr 71TCr 5.63TCr 5.51TCr 2,43700Cr P/E 2026 *
45.1x
P/E 2027 * 32.8x
Enterprise Value 46TCr 1.42TCr 1.24TCr 1.15TCr 1.06TCr 1.99TCr 1,36700Cr 2.02TCr 14TCr 5.38TCr 67TCr 5.32TCr 5.21TCr 2,30400Cr EV / Sales 2026 *
18.3x
EV / Sales 2027 * 13x
Free-Float
75.37%
Yield 2026 *
0.08%
Yield 2027 * 0.12%
1 day-1.67%
1 week-6.00%
Current month-2.73%
1 month+22.96%
3 months+98.09%
6 months+123.95%
Current year+177.32%
1 week 1,175
Extreme 1175
1,365
1 month 915.01
Extreme 915.0097
1,415.34
Current year 423.7
Extreme 423.6991
1,415.34
1 year 395.61
Extreme 395.6133
1,415.34
3 years 222.58
Extreme 222.5833
1,415.34
5 years 56.05
Extreme 56.052
1,415.34
10 years 43.54
Extreme 43.5418
1,415.34
Manager TitleAgeSince
Chief Executive Officer - 01/01/2003
Director of Finance/CFO - 14/10/2015
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman - 01/09/2003
Director/Board Member - -
Director/Board Member - 30/06/2009
Change 5-day change 1-year change 3-year change Capi.($)
-1.67%-6.00%+163.95%+284.69% 1.5TCr
+0.21%-0.79%+53.17%+57.39% 5.38TCr
+5.37%+3.31%+50.39%+83.65% 5.47TCr
-1.20%-1.94%+4.35%+402.68% 2.32TCr
+0.74%+2.32%-16.23%-14.44% 2.33TCr
+2.56%+2.62%+40.00%-3.69% 2TCr
-1.18%-2.97%+30.12%-33.30% 1.73TCr
+0.30%+1.36%+33.74%+577.85% 1.54TCr
-0.70%-0.91%+24.87%+179.47% 1.4TCr
-3.21%+0.88%+60.32%+151.29% 1.24TCr
Average +0.10%-0.56%+44.47%+168.56% 2.49TCr
Weighted average by Cap. +1.01%-0.84%+43.09%+134.70%

Financials

2026 *2027 *
Net sales 2.51TCr 78Cr 68Cr 63Cr 58Cr 109.1Cr 7.48TCr 110.85Cr 751.76Cr 294.69Cr 3.66TCr 291.39Cr 285.03Cr 13TCr 3.46TCr 107Cr 94Cr 87Cr 80Cr 150.44Cr 10TCr 152.85Cr 1.04TCr 406.35Cr 5.05TCr 401.79Cr 393.03Cr 17TCr
Net income 1.09TCr 34Cr 29Cr 27Cr 25Cr 47Cr 3.24TCr 48Cr 325.51Cr 127.6Cr 1.59TCr 126.17Cr 123.42Cr 5.46TCr 1.5TCr 46Cr 41Cr 38Cr 35Cr 65Cr 4.47TCr 66Cr 448.98Cr 176Cr 2.19TCr 174.03Cr 170.23Cr 7.53TCr
Net Debt -2.65TCr -82Cr -72Cr -67Cr -61Cr -115.44Cr -7.92TCr -117.29Cr -795.43Cr -311.81Cr -3.87TCr -308.31Cr -301.59Cr -13TCr -3.47TCr -107.5Cr -94Cr -87Cr -80Cr -151.14Cr -10TCr -153.57Cr -1.04TCr -408.25Cr -5.07TCr -403.67Cr -394.87Cr -17TCr
Logo PharmaEssentia Corporation
PharmaEssentia Corp is a Taiwan-based company mainly engaged in the research, development, production and sale of new drugs. The Company is engaged in the research and development of new drugs, which are used for treatment of hematology, such as meloproliferative neoplasms (MPN), neutropenia, anemia; infectious disease, such as hepatitis C and hepatitis B; dermatology, such as psoriasis, and neurology, such as multiple sclerosis, among others. The Company’s products include KX01, P1101, Polycythemia Vera (PV), PEG-GCSF, PEG-EPO and others. The Company distributes its products within domestic market and to overseas markets.
Employees
131
Date Price Change Volume
20/26/20 NT$1,175.00 -1.67% 29,26,691
17/26/17 NT$1,195.00 -5.16% 33,77,763
16/26/16 NT$1,260.00 -4.55% 44,20,281
15/26/15 NT$1,320.00 +10.00% 21,57,754
14/26/14 NT$1,200.00 -4.00% 40,37,292
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
1,175.00TWD
Average target price
1,073.31TWD
Spread / Average Target
-8.65%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 6446 Stock